pNICKclos1.0 Citations (2)
Originally described in: CRISPR-based genome editing and expression control systems in Clostridium acetobutylicum and Clostridium beijerinckii.Li Q, Chen J, Minton NP, Zhang Y, Wen Z, Liu J, Yang H, Zeng Z, Ren X, Yang J, Gu Y, Jiang W, Jiang Y, Yang S Biotechnol J. 2016 May 23. doi: 10.1002/biot.201600053. PubMed Journal
Articles Citing pNICKclos1.0
Articles |
---|
Improved electrocompetence and metabolic engineering of Clostridium pasteurianum reveals a new regulation pattern of glycerol fermentation. Schmitz R, Sabra W, Arbter P, Hong Y, Utesch T, Zeng AP. Eng Life Sci. 2018 Nov 28;19(6):412-422. doi: 10.1002/elsc.201800118. eCollection 2019 Jun. PubMed |
Methods and Techniques to Facilitate the Development of Clostridium novyi NT as an Effective, Therapeutic Oncolytic Bacteria. Dailey KM, Jacobson RI, Johnson PR, Woolery TJ, Kim J, Jansen RJ, Mallik S, Brooks AE. Front Microbiol. 2021 Mar 29;12:624618. doi: 10.3389/fmicb.2021.624618. eCollection 2021. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.